110 related articles for article (PubMed ID: 18162179)
1. Covalent modification of stathmin by CCNU determined by FTMS analysis of modified proteins and tryptic peptides.
Wu WW; Wang G; Liang XJ; Park JK; Shen RF
Biochem Biophys Res Commun; 2008 Feb; 367(1):7-13. PubMed ID: 18162179
[TBL] [Abstract][Full Text] [Related]
2. Modification of calmodulin on Lys-75 by carbamoylating nitrosoureas.
Mann DM; Vanaman TC
J Biol Chem; 1988 Aug; 263(23):11284-90. PubMed ID: 3136156
[TBL] [Abstract][Full Text] [Related]
3. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.
Hartley JA; Gibson NW; Kohn KW; Mattes WB
Cancer Res; 1986 Apr; 46(4 Pt 2):1943-7. PubMed ID: 3004713
[TBL] [Abstract][Full Text] [Related]
4. Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells.
Liang XJ; Choi Y; Sackett DL; Park JK
Cancer Res; 2008 Jul; 68(13):5267-72. PubMed ID: 18593927
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic analysis of the interaction of lomustine with calf thymus DNA.
Agarwal S; Jangir DK; Singh P; Mehrotra R
J Photochem Photobiol B; 2014 Jan; 130():281-6. PubMed ID: 24368412
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of deamidation in lens betaB2-crystallin and peptides by direct electrospray injection and fragmentation in a Fourier transform mass spectrometer.
Robinson NE; Lampi KJ; McIver RT; Williams RH; Muster WC; Kruppa G; Robinson AB
Mol Vis; 2005 Dec; 11():1211-9. PubMed ID: 16402021
[TBL] [Abstract][Full Text] [Related]
7. Bioconjugation of ribonuclease A: a detailed chromatographic and mass spectrometric analysis of chemical modification by a cross-linking reagent.
Méndez TJ; Johnson JV; Nichols LS; Lang GH; Eyler JR; Powell DH; Richardson DE
Bioconjug Chem; 2000; 11(2):182-94. PubMed ID: 10725095
[TBL] [Abstract][Full Text] [Related]
8. Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats.
Bethune C; Blum A; Geyer JR; Silber JR; Ho RJ
Pharm Res; 1999 Jun; 16(6):896-903. PubMed ID: 10397611
[TBL] [Abstract][Full Text] [Related]
9. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology.
Inga A; Iannone R; Monti P; Molina F; Bolognesi M; Abbondandolo A; Iggo R; Fronza G
Oncogene; 1997 Mar; 14(11):1307-13. PubMed ID: 9178891
[TBL] [Abstract][Full Text] [Related]
10. Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
Gadjeva V; Lazarova G; Zheleva A
Toxicol Lett; 2003 Oct; 144(3):289-94. PubMed ID: 12927347
[TBL] [Abstract][Full Text] [Related]
11. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
Wu SL; Kim J; Hancock WS; Karger B
J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
[TBL] [Abstract][Full Text] [Related]
12. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.
Bethune CR; Geyer RJ; Spence AM; Ho RJ
Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837
[TBL] [Abstract][Full Text] [Related]
13. [Suppression of nitric oxide on cytotoxicity of Lomustine in glioma cell line BT- 325].
Gao RL; Chen ZL
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 32(6):519-24, 528. PubMed ID: 14712517
[TBL] [Abstract][Full Text] [Related]
14. Electrochemical behaviour of anticancer drug lomustine and in situ evaluation of its interaction with DNA.
de Carvalho PAV; Campelo Lopes I; Silva EHC; Bruzaca EES; Alves HJ; Lima MIS; Tanaka AA
J Pharm Biomed Anal; 2019 Nov; 176():112786. PubMed ID: 31398506
[TBL] [Abstract][Full Text] [Related]
15. Selective bridging of bis-cysteinyl residues by arsonous acid derivatives as an approach to the characterization of protein tertiary structures and folding pathways by mass spectrometry.
Happersberger HP; Przybylski M; Glocker MO
Anal Biochem; 1998 Nov; 264(2):237-50. PubMed ID: 9866689
[TBL] [Abstract][Full Text] [Related]
16. Structure characterization of functional histidine residues and carbethoxylated derivatives in peptides and proteins by mass spectrometry.
Kalkum M; Przybylski M; Glocker MO
Bioconjug Chem; 1998; 9(2):226-35. PubMed ID: 9548538
[TBL] [Abstract][Full Text] [Related]
17. Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas.
Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2000 Feb; 59(3):283-91. PubMed ID: 10609557
[TBL] [Abstract][Full Text] [Related]
18. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
Stritzelberger J; Distel L; Buslei R; Fietkau R; Putz F
Clin Transl Oncol; 2018 Apr; 20(4):508-516. PubMed ID: 28825189
[TBL] [Abstract][Full Text] [Related]
19. Characterization of reaction conditions providing rapid and specific cysteine alkylation for peptide-based mass spectrometry.
Paulech J; Solis N; Cordwell SJ
Biochim Biophys Acta; 2013 Jan; 1834(1):372-9. PubMed ID: 22910378
[TBL] [Abstract][Full Text] [Related]
20. Chemical-modification rescue assessed by mass spectrometry demonstrates that gamma-thia-lysine yields the same activity as lysine in aldolase.
Hopkins CE; O'Connor PB; Allen KN; Costello CE; Tolan DR
Protein Sci; 2002 Jul; 11(7):1591-9. PubMed ID: 12070312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
